Mireinio a lleihau canlyniadau drwy ychwanegu cysyniadau cysylltiedig
100
Insulin Derivative
| Cysyniad: | Insulin Derivative |
| Pwysau: | 100% |
| Parth: | Chemistry |
100
Coumarin
| Cysyniad: | Coumarin |
| Pwysau: | 100% |
| Parth: | Chemistry |
66
Structure
| Cysyniad: | Structure |
| Pwysau: | 66% |
| Parth: | Chemistry |
33
Antifungal
| Cysyniad: | Antifungal |
| Pwysau: | 33% |
| Parth: | Chemistry |
33
Glimepiride
| Cysyniad: | Glimepiride |
| Pwysau: | 33% |
| Parth: | Chemistry |
33
Glucose
| Cysyniad: | Glucose |
| Pwysau: | 33% |
| Parth: | Chemistry |
33
X-Ray
| Cysyniad: | X-Ray |
| Pwysau: | 33% |
| Parth: | Chemistry |
33
Spectra
| Cysyniad: | Spectra |
| Pwysau: | 33% |
| Parth: | Chemistry |
33
Bioactivity
| Cysyniad: | Bioactivity |
| Pwysau: | 33% |
| Parth: | Chemistry |
33
Sulfur
| Cysyniad: | Sulfur |
| Pwysau: | 33% |
| Parth: | Chemistry |
33
Two-Dimensional NMR
| Cysyniad: | Two-Dimensional NMR |
| Pwysau: | 33% |
| Parth: | Chemistry |
33
Single Crystalline ...
| Cysyniad: | Single Crystalline Solid |
| Pwysau: | 33% |
| Parth: | Chemistry |
100
Coumarin Derivative
| Cysyniad: | Coumarin Derivative |
| Pwysau: | 100% |
| Parth: | Medicine and Dentistry |
66
Insulin Release
| Cysyniad: | Insulin Release |
| Pwysau: | 66% |
| Parth: | Medicine and Dentistry |
66
X-Ray
| Cysyniad: | X-Ray |
| Pwysau: | 66% |
| Parth: | Medicine and Dentistry |
66
Two-Dimensional Nuc...
| Cysyniad: | Two-Dimensional Nuclear Magnetic Resonance Spectroscopy |
| Pwysau: | 66% |
| Parth: | Medicine and Dentistry |
50
Patient
| Cysyniad: | Patient |
| Pwysau: | 50% |
| Parth: | Medicine and Dentistry |
50
Actinobacteria
| Cysyniad: | Actinobacteria |
| Pwysau: | 50% |
| Parth: | Medicine and Dentistry |
50
Gene
| Cysyniad: | Gene |
| Pwysau: | 50% |
| Parth: | Medicine and Dentistry |
33
Glimepiride
| Cysyniad: | Glimepiride |
| Pwysau: | 33% |
| Parth: | Medicine and Dentistry |
33
Biological Activity
| Cysyniad: | Biological Activity |
| Pwysau: | 33% |
| Parth: | Medicine and Dentistry |
33
Multiple Sclerosis
| Cysyniad: | Multiple Sclerosis |
| Pwysau: | 33% |
| Parth: | Medicine and Dentistry |
33
Antifungal Activity
| Cysyniad: | Antifungal Activity |
| Pwysau: | 33% |
| Parth: | Medicine and Dentistry |
33
Stimulation
| Cysyniad: | Stimulation |
| Pwysau: | 33% |
| Parth: | Medicine and Dentistry |
33
Chemotherapeutic Ag...
| Cysyniad: | Chemotherapeutic Agent |
| Pwysau: | 33% |
| Parth: | Medicine and Dentistry |
33
Sulfur
| Cysyniad: | Sulfur |
| Pwysau: | 33% |
| Parth: | Medicine and Dentistry |
33
Drug
| Cysyniad: | Drug |
| Pwysau: | 33% |
| Parth: | Medicine and Dentistry |
33
Pancreatic Islet
| Cysyniad: | Pancreatic Islet |
| Pwysau: | 33% |
| Parth: | Medicine and Dentistry |
33
Antidiabetic Agent
| Cysyniad: | Antidiabetic Agent |
| Pwysau: | 33% |
| Parth: | Medicine and Dentistry |
33
Phytochemical
| Cysyniad: | Phytochemical |
| Pwysau: | 33% |
| Parth: | Medicine and Dentistry |
20
Glycogen
| Cysyniad: | Glycogen |
| Pwysau: | 20% |
| Parth: | Medicine and Dentistry |
20
Gene Insertion Sequ...
| Cysyniad: | Gene Insertion Sequence |
| Pwysau: | 20% |
| Parth: | Medicine and Dentistry |
100
Coumarin Derivative
| Cysyniad: | Coumarin Derivative |
| Pwysau: | 100% |
| Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
33
Glimepiride
| Cysyniad: | Glimepiride |
| Pwysau: | 33% |
| Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
33
Phytochemical
| Cysyniad: | Phytochemical |
| Pwysau: | 33% |
| Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
33
Sulfur
| Cysyniad: | Sulfur |
| Pwysau: | 33% |
| Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
33
Antidiabetic Agent
| Cysyniad: | Antidiabetic Agent |
| Pwysau: | 33% |
| Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
33
Drug
| Cysyniad: | Drug |
| Pwysau: | 33% |
| Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
33
Medicinal Plant
| Cysyniad: | Medicinal Plant |
| Pwysau: | 33% |
| Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
33
Insulin
| Cysyniad: | Insulin |
| Pwysau: | 33% |
| Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
33
Glucose
| Cysyniad: | Glucose |
| Pwysau: | 33% |
| Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
33
Multiple Sclerosis
| Cysyniad: | Multiple Sclerosis |
| Pwysau: | 33% |
| Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
Canfuwyd 4 o arbenigwyr gydag allbwn ymchwil yn gysylltiedig i'r holl gysyniadau a ddewiswyd
Ystod Allbwn Ymchwil